Background: In recent years, multiresistant Pasteurella multocida isolates from bovine respiratory tract infections have been identified. These isolates have exhibited resistance to most classes of antimicrobial agents commonly used in veterinary medicine, the genetic basis of which, however, is largely unknown.
Introduction
Bovine respiratory disease (BRD) is an economically important disease. Global losses of the feedlot industry are estimated to be .$3 billion/year. 1 BRD is a multifactorial and multiagent disease whose colloquial designation, 'shipping fever', refers to some of the factors that play a relevant role in the development of the disease. Transportation over long distances, often associated with exhaustion, starvation, dehydration, chilling or overheating, depending on weather conditions, serves as a stressor. Additional stressors include passage through auction markets, commingling of animals from different herds, dusty environmental conditions in the feedlot and nutritional stress associated with changes in diet. 2 Initial viral infections may pave the way for subsequent bacterial infections, in which Mannheimia haemolytica, Pasteurella multocida and Histophilus somni are the most important pathogens. 1 Antimicrobial agents are commonly used to combat bacteria involved in BRD.
3,4 Analysis of the susceptibility status of bovine P. multocida isolates from respiratory tract infections conducted in different European countries during the ARBAO-II study 2003-05 revealed, in general, low percentages of resistance, which proved to be particularly true for newer antimicrobial agents such as ceftiofur, cefquinome, florfenicol and fluoroquinolones. 5 Corresponding data from the GERM-Vet programme 2004-05 in Germany confirmed the low MIC 90 values and the corresponding low percentages of resistant strains-if present at all-not only for the aforementioned antimicrobial agents, but also for the triamilide tulathromycin. 6 Tulathromycin was approved in 2005 in the European Union and the USA for use in the treatment and control of BRD and the treatment of swine respiratory disease. 7 Pfizer Animal Health has conducted continuous surveillance of the tulathromycin susceptibility status of the target pathogens. Single tulathromycin-resistant strains have been detected, which mostly showed resistance to numerous other antimicrobial agents commonly used in the treatment of cattle and other animals. To identify the gene(s) responsible for resistance to tulathromycin and the macrolide tilmicosin in the representative multiresistant and plasmid-free isolate P. multocida 36950, a whole genome sequencing approach was chosen followed by a matched assembly against the P. multocida strain Pm70. 8 This approach resulted in the identification of the gene erm (42) , which conferred resistance to macrolides and lincosamides, as well as msr(E)-mph(E), which mediate resistance to macrolides and triamilides. 9 The aim of the present study was to: (i) determine the complete genetic basis of the expanded multiresistance phenotype of P. multocida 36950; (ii) investigate whether erm(42) and msr(E)-mph(E) are linked to other resistance genes; and (iii) determine whether the resistance genes identified in P. multocida 36950 are part of a transferable element.
Materials and methods

Bacterial strain and susceptibility testing
The P. multocida strain 36950 was obtained from a case of bovine respiratory tract infection in a Nebraska feedlot in 2005. Antimicrobial susceptibility testing was performed by broth microdilution using custom-made microtitre panels (MCS Diagnostics, Swalmen, The Netherlands). For this, 18 antimicrobial agents and two combinations of antimicrobial agents were tested in 10-12 concentrations in 2-fold dilution series. These comprised penicillins [penicillin G, ampicillin, amoxicillin/clavulanic acid (2: 1) and oxacillin], cephalosporins (cefalotin, cefotaxime, cefquinome and ceftiofur), tetracyclines (tetracycline), macrolides (erythromycin, tilmicosin and tulathromycin), lincosamides (clindamycin), folate pathway inhibitors [trimethoprim and sulfamethoxazole/trimethoprim (19 : 1)], an aminoglycoside (gentamicin), an aminocyclitol (spectinomycin), phenicols (chloramphenicol and florfenicol) and a fluoroquinolone (enrofloxacin). In addition, MICs of streptomycin, kanamycin and neomycin were determined by broth macrodilution using a 2-fold dilution series of 0.5-32 mg/L (streptomycin) or 0.5-16 mg/L (kanamycin and neomycin). Performance of the tests and the evaluation of MIC values followed the recommendations given in document M31-A3 of the CLSI. 10 The reference strains Staphylococcus aureus ATCC 29213 and Escherichia coli ATCC 25922 served as quality control strains.
Whole genome sequence analysis and analysis of resistance genes and mutations Genomic DNA was prepared as previously described. 11 For whole genome sequencing, a shotgun library and a long-tag paired end library were generated using the 454 Life Sciences (Roche) GS-FLX system (Eurofins MWG, Ebersberg, Germany). PCR assays were performed and the amplicons sequenced to close the gaps between the different contigs. Genes were predicted by the YACOP 12 and the ORF Finder programs (http://www. ncbi.nlm.nih.gov/projects/gorf/). The predicted coding sequences (CDSs) were compared with the SWISSProt/EMBL databases and manually curated using the annotation software ERGO. 13 For detailed sequence comparisons the BlastN and BlastP programs (http://blast.ncbi.nlm.nih. gov/) were also used. The GC content of ICEPmu1 was determined using the Artemis genome browser and annotation tool. 14 The whole genome sequence of P. multocida 36950 has been deposited in GenBank under accession number CP003022.
Results and discussion P. multocida 36950 exhibited resistance to most antimicrobial agents approved for the control of bovine respiratory diseases. This included resistance to older antimicrobial agents such as tetracyclines (32 mg/L), chloramphenicol (16 mg/L), sulphonamides (≥512 mg/L) and spectinomycin (≥512 mg/L), but also to newer agents such as enrofloxacin (2 mg/L), florfenicol (8 mg/L), tilmicosin (≥128 mg/L) and tulathromycin (≥128 mg/L). Moreover, high MICs of the aminoglycosides streptomycin (≥64 mg/L), gentamicin (128 mg/L), kanamycin and neomycin (≥32 mg/L each) were detected. The resistance genes found in P. multocida 36950 were located in resistance gene regions 1 and 2, which were located 42526 bp apart from each other. Comparisons of the whole genome sequence of P. multocida 36950 with the genome sequence of P. multocida Pm70 identified an 82 kb element that was present in P. multocida 36950, but absent in P. multocida Pm70. This element included the resistance gene region 1 at its left terminus and the resistance gene region 2 close to its right terminus. A schematic presentation of the ICE of P. multocida 36950, designated ICEPmu1, is shown in Figure 1 (a), whereas detailed presentations of the resistance gene regions 1 and 2, including their relationships to sequences of previously described plasmids, transposons, insertion elements and genomic islands, are shown in Figure 1 (b and c). ICEPmu1 showed a G+ C content (41.9%) different from that of the genome of its host (40.4%). The G +C content graphic clearly shows that the higher G + C content of ICEPmu1 resulted from the higher G + C content of the sequences present in the two resistance gene regions ( Figure 1a ). While this study focused on the identification and the linkage of the resistance genes, the accompanying study concentrated on the characterization of ICEPmu1, its mobility across genus boundaries and its integration in different hosts. 15 Data for the expression of ICEPmu1-associated resistance genes in bacteria of the same and other species and genera (e.g. M. haemolytica and E. coli) after conjugative transfer of ICEPmu1 are presented in the accompanying study. These data suggest that certain resistance genes are either functionally inactive (e.g. bla OXA-2 ) or associated with distinctly lower MIC values (e.g. floR) for Pasteurellaceae as compared with E. coli.
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Resistance gene region 1
Resistance gene region 1 is 15711 bp in size and is bracketed by copies of the insertion element ISApl1 originally identified in the chromosomal DNA of the porcine respiratory tract pathogen Actinobacillus pleuropneumoniae. 16 This insertion sequence is 1070 bp in size and exhibits 27 bp imperfect inverted repeated sequences at its boundaries as well as a single reading frame for a transposase of 307 amino acids. ISApl1 belongs to the IS30 family and has been reported to produce a 2 bp direct duplication Figure 1 . Schematic presentation of ICEPmu1 (a) and the resistance gene regions 1 (b) and 2 (c). Genes are presented as arrows, with the arrowhead indicating the direction of transcription. Insertion sequences and ISCR elements are shown as boxes, with the arrows inside the boxes indicating the transposase genes. Grey-shaded areas indicate areas of .95% sequence identity between ICEPmu1 and plasmid pIE1130 from an uncultured eubacterium (accession number AJ271879), plasmid pPDP9106b (accession number AB601890) of P. damselae subsp. piscicida, the antibiotic resistance gene cluster of the SXT element of V. cholerae strain MO10 (accession number AY034138), transposon Tn5706 (accession number Y15510), class 1 integrons of Proteus mirabilis (accession number DQ520939) and of B. bronchiseptica (accession number AJ877267), plasmid pKP048 of K. pneumoniae (accession number FJ628167) and the complete genome of M. succiniciproducens MBEL55E (accession number NC_006300.1).
at its integration site. 16 Upon inspection of the sequences immediately up-and downstream of each of the two copies of ISApl1, the repeated sequence GT was detected upstream of the right-hand copy and downstream of the left-hand copy of ISApl1. This might suggest that the entire resistance gene region 1 was inserted via an ISApl1-mediated integration or recombination process. It should be noted that the left-hand ISApl1 is complete, whereas a single bp exchange generated an early stop codon after codon 104 in the tnp sequence of the right-hand ISApl1. Almost in the middle of resistance gene region 1, a novel ISCR element designated ISCR21 was detected. ISCR21 is 1751 bp in size and has a single reading frame for a 430 amino acid transposase, which is next related (83.5% identity and 89.1% homology) to the recently described transposase of ISCR20 from E. coli.
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Upstream of ISCR21, the four resistance genes sul2, strA, strB and aphA1, all oriented in the same direction, were identified. The gene sul2 codes for a dihydropteroate synthase of 281 amino acids that confers sulphonamide resistance. It should be noted that the start codon and the adjacent 10 codons in the 5 ′ terminus of the gene differed completely from the sequences of any other known sul2 gene. The amino acid sequence deduced from codons 12-281 was indistinguishable from that of the 271 amino acid Sul2 proteins commonly found among Pasteurellaceae and other organisms.
3 A 168 bp spacer separated the sul2 gene from the strA gene. An identical spacer sequence was seen in plasmid pB1003 from P. multocida, 18 pPASS1 from Pasteurella aerogenes 19 and pMS260 from A. pleuropneumoniae. 20 The gene strA codes for a 267 amino acid aminoglycoside 3 ′′ -phosphotransferase. The terminal 'A' in the translational stop codon of the strA gene represented the initial 'A' in the start codon of the gene strB (-TGATG-). The gene strB codes for a 278 amino acid aminoglycoside 6-phosphotransferase. Both genes are involved in streptomycin resistance. The deduced StrA and StrB amino acid sequences were indistinguishable from those found in a wide variety of bacteria. However, it is noteworthy that complete strB genes have been detected rarely in P. multocida, 21, 22 whereas truncated strB genes are commonly seen. 3, 4, 18, 19 Another 335 bp downstream of strB, a third aminoglycoside resistance gene, aphA1 [also known as aph(3 ′ )-I], was detected. This gene codes for a different type of aminoglycoside 3 ′ -phosphotransferase, which confers resistance to kanamycin and neomycin. The 271 amino acid AphA1 protein showed 99.6% -100% identity to the corresponding proteins of Avibacterium paragallinarum and A. pleuropneumoniae.
23,24
The sul2-strA-strB-aphA1 segment showed 99.8% nucleotide sequence identity to the corresponding sequence of the IncQ-like plasmid pIE1130 from an uncultured eubacterium (accession number AJ271879) (Figure 1b) . Downstream of ISCR21, the terminal 257 bp of an ISCR2-associated transposase gene as well as the adjacent 234 bp of the ISCR2 element were detected. Downstream of this ISCR2 relic, the gene floR for a 404 amino acid phenicol-specific exporter protein of the major facilitator superfamily (MFS) was located. The FloR protein differed by 1 -4 amino acids from the FloR proteins previously described, including those found in P. multocida, 21, 25 Bibersteinia (formerly Pasteurella) trehalosi 26 and Vibrio cholerae. 27 The floR gene was followed by a gene for a 101 amino acid LysR transcriptional regulator protein whose reading frame overlapped by 6 bp with the sequence of a complete ISCR2 element of 1845 bp. Another 185 bp downstream of ISCR2, the rRNA methylase gene erm(42) was detected. This gene has recently been shown to confer resistance to 14-and 16-membered macrolides, such as erythromycin and tilmicosin, as well as to lincosamides. 9 Database searches revealed that the 301 amino acid Erm(42) protein is only distantly related (,30% identity) to other Erm proteins, but is indistinguishable from the 301 amino acid protein Erm(42) of P. multocida and M. haemolytica 28 and shows 99.3% identity to an erythromycin resistance protein of 303 amino acids from plasmid pPDP9106b (accession number AB601890) of a fish-pathogenic Photobacterium damselae subsp. piscicida strain (formerly known as Pasteurella piscicida). The entire floR-lysR-ISCR2-erm(42) region showed 96.2% sequence identity to that of plasmid pPDP9106b (Figure 1b) . Moreover, the sul2-strA-strB segment as well as the DISCR2-floRlysR-ISCR2 segment were present in the SXT element of V. cholerae, 27 even if in different orientations and not interrupted by an ISCR21 element (Figure 1b ).
Resistance gene region 2
Resistance gene region 2 is 9789 bp in size and comprises a total of six different resistance genes as well as two regulatory genes and two complete insertion sequences (Figure 1c) . The left-hand part is characterized by a largely truncated transposon Tn5706, 29 of which only the repressor gene tetR, including 95 bp of the downstream region and 133 bp of the upstream region, remained. The 133 bp, however, included the spacer region between tetR and the tetracycline resistance gene tet(H), with the promoters required for tetR and tet(H) transcription as well as the 5 ′ end of the tet(H) reading frame. Detailed analysis revealed that a recombination between the initial part of the tet(H) gene and the att1 site of a class 1 integron occurred (Figure 2a) . As a consequence, the three resistance gene cassettes present in this class 1 integron also became integrated into the chromosomal DNA of P. multocida 36950. The first gene cassette is 591 bp in size, has a 59-base element of 60 bp and contains an aadB gene encoding a 177 amino acid aminoglycoside 2 ′′ -O-adenyltransferase, which confers gentamicin resistance (Figure 2b ). The AadB protein was indistinguishable from a wide variety of AadB proteins from Gramnegative bacteria deposited in the databases. However, to the best of our knowledge, this is the first report of a gentamicin resistance gene in P. multocida. The second gene cassette is 856 bp in size, also has a 59-base element of 60 bp and harbours a novel aadA gene variant, designated aadA25, for combined resistance to streptomycin and spectinomycin (Figure 2b) . The deduced sequence of the 259 amino acid AadA25 protein differed by five amino acid exchanges from the next related variants AadA21 or AadA3c. 30, 31 The third gene cassette is 876 bp in size, has a 59-base element of 70 bp and contains the gene bla OXA-2 , which codes for a narrow-spectrum b-lactamase of 275 amino acids (Figure 2b ). While database searches identified bla OXA-2 genes indistinguishable from that of P. multocida 36950 mainly in Enterobacteriaceae and Pseudomonas aeruginosa, this gene has not been seen before in P. multocida. However, it has been described as part of a plasmid-borne gene cassette in the porcine respiratory tract pathogen Bordetella bronchiseptica. Transfer experiments as conducted in the accompanying study confirmed these observations for P. multocida and M. haemolytica hosts, but also showed that the bla OXA-2 gene was functionally active in E. coli.
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Immediately downstream of the 59-base element of the bla OXA-2 gene cassette, a 4386 bp segment was found that consisted of the genes msr(E)-mph(E) bracketed by two IS26 elements located in the same orientation (Figure 1c) . Insertion sequences of the type IS26 are widespread among Enterobacteriaceae, but have rarely been seen in Pasteurellaceae. 26 IS26 is 859 bp in size, exhibits 14 bp terminal perfect inverted repeats and produces 8 bp direct repeats at its integration site. 33 The msr(E) gene codes for an ABC transporter protein of 491 amino acids while the mph(E) gene codes for a macrolide phosphotransferase protein of 294 amino acids. These two genes are organized in an operon-like structure and are separated by a non-coding spacer sequence of 55 bp. A recent study confirmed that the genes msr(E)-mph(E) confer resistance not only to 14-and 16-membered macrolides, but also to the triamilide tulathromycin. 9 Database searches identified these genes on plasmids in Klebsiella pneumoniae and other Enterobacteriaceae 34 -36 as well as in Acinetobacter baumannii, 37, 38 where they have been The sixth resistance gene in region 2, the tetracycline resistance gene tet(H) accompanied by its repressor gene tetR, was located in another truncated Tn5706 element, which was found 106 bp downstream of the right-hand IS26. Both terminal insertion sequences IS1596 and IS1597 present in the composite transposon Tn5706 29 were absent. The Tn5706-homologous sequence in the part downstream of tetR stopped exactly at the position where otherwise the IS1596 sequence was found. In the part downstream of tet(H), the Tn5706-homologous sequence stopped 65 bp after the translational stop codon of tet(H). Immediately thereafter, perfect nucleotide sequence identity to the whole genome sequence of Mannheimia succiniciproducens MBEL55E was observed (Figure 1c) . The tet(H) gene found in P. multocida 36950 codes for a 400 amino acid tetracycline efflux protein of the major facilitator family. It differed by a single homologous amino acid exchange, N258H, from the Tet(H) protein of Tn5706.
In summary, the two resistance gene regions contained a total of 12 different resistance genes, some of which-e.g. tet(H), sul2, strA and strB-have previously been reported to be present mostly on plasmids in P. multocida or other members of the family Pasteurellaceae.
3,4 Other resistance genes-e.g. floR and aphA1-have rarely been seen in P. multocida or other bovine respiratory tract pathogens. The third group of resistance genes-e.g. erm(42), msr(E) and mph(E), as well as the cassette-borne genes aadB, aadA25 and bla OXA-2 -are novel genes in P. multocida. The structural comparisons as shown in Figure 1 (b and c) strongly suggest that both resistance gene regions have developed as a result of integration and recombination processes in which insertion sequences and ISCR elements seem to have played a key role. Moreover, analysis of the two resistance gene regions clearly showed that P. multocida is able to: (i) acquire resistance genes from other Gram-negative bacteria; (ii) incorporate them into its chromosomal DNA; and (iii) use these genes to gain resistance to the respective antimicrobial agents.
Resistance-mediating mutations in P. multocida 36950
Besides the resistance genes identified in resistance gene regions 1 and 2 of ICEPmu1, P. multocida 36950 exhibited resistance to antimicrobial agents such as spectinomycin and enrofloxacin, for which resistance is often based on mutations in specific target genes.
In addition to enzymatic inactivation via AadA proteins, highlevel resistance to spectinomycin in P. multocida can also be due to mutations in a specific region of the 16S rRNA and/or in the gene rpsE coding for the ribosomal protein S5. 39 Comparisons of the 16S rRNA sequence of all six operons and analysis of the rpsE sequence did not reveal changes that point towards an involvement of mutations in these targets in the observed spectinomycin resistance.
Fluoroquinolone resistance in P. multocida and other bovine respiratory tract pathogens has very rarely-if at all-been observed. As in many other bacteria, quinolone/fluoroquinolone resistance is most likely due to mutations in the genes gyrA and parC encoding DNA gyrase and topoisomerase IV. 40 Analysis of the quinolone resistance-determining regions (QRDRs) within the genes gyrA and parC identified in P. multocida 36950 showed two bp exchanges in the QRDR of gyrA, which resulted in amino acid alterations; GGT AGT (Gly75 to Ser75) and AGC AGA (Ser83 to Arg83). In addition, a single bp exchange in the QRDR of parC, TCA TTA, which resulted in a Ser80-to-Leu80 exchange, was also seen in P. multocida 36950. While single amino acid exchanges within the QRDR of GyrA are usually only associated with resistance to the quinolone nalidixic acid, two or more amino acid exchanges in the QRDRs of GyrA and ParC accompany resistance to fluoroquinolones such as enrofloxacin. While alterations at codon 75 in gyrA have rarely been detected, 41 alterations at codon 83 in gyrA and at codon 80 in parC have frequently been described in connection with fluoroquinolone resistance in other bacteria. 42 -44 In P. multocida, only a single gyrA mutation, AGC ATC, which results in a Ser83-to-Ile83 exchange, has been associated with high-level resistance to nalidixic acid (MIC .256 mg/L), but susceptibility to ciprofloxacin (MIC 0.12 mg/L). 40 The mutations detected in gyrA and parC of P. multocida 36950 are, to the best of our knowledge, the first examples of fluoroquinolone resistance-mediating mutations in P. multocida.
